Compare SRRK & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | CROX |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.4B |
| IPO Year | 2018 | 2006 |
| Metric | SRRK | CROX |
|---|---|---|
| Price | $46.63 | $83.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $49.80 | ★ $96.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.26 |
| Revenue | N/A | ★ $4,072,780,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20,271.77 | N/A |
| P/E Ratio | ★ N/A | $26.17 |
| Revenue Growth | N/A | ★ 0.01 |
| 52 Week Low | $22.71 | $73.21 |
| 52 Week High | $48.28 | $122.84 |
| Indicator | SRRK | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 42.32 |
| Support Level | $40.63 | $83.95 |
| Resistance Level | $44.50 | $88.25 |
| Average True Range (ATR) | 2.09 | 3.25 |
| MACD | -0.17 | -0.64 |
| Stochastic Oscillator | 87.00 | 4.11 |
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.